-
Mashup Score: 0Factors Associated with Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System - 1 year(s) ago
The availability of asthma biologics may not benefit all patients equally.
Categories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1
The increasing availability of biologics, both by expanding age indications and by development of new therapies, provides additional options to treat children and adolescents with severe asthma. However, the evidence for these biologics in these populations is limited compared with that for adult studies. As such, before initiation of therapy, possible alternative therapies that can also provide…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Factors to Consider in #Prescribing #Asthma #Biologic #Therapies to #Children https://t.co/om8D5hTRsd https://t.co/SZo1n74XpL
-
-
Mashup Score: 2Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype? - 1 year(s) ago
Defining super-response to biologic treatment is a major concern in severe asthma. Although many definitions have been proposed, there is still a gap between the clinical perception of the super-response and a standardized classification. The current definition of super-response mainly relies on several clinical features, while many aspects of severe asthma inflammation and lung function are…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! Super-Responders to #Biologic #Treatment in Type 2–High Severe #Asthma: Passing Fad or a Meaningful #Phenotype? https://t.co/nAtVaaH0IG https://t.co/npaigE0HVw
-
-
Mashup Score: 0‘Why not combine them?’: Early dual biologic therapy may overcome limits in severe IBD - 1 year(s) ago
DENVER — Early data suggest combination therapy with biologics or advanced small-molecules may be safe and effective in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.“We have all these different mechanisms of action right now — in newer development are some of the oral and p-19 [inhibitors],” Edward V. Loftus
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
‘Why not combine them," @EdwardLoftus2 said at #CCCongress23. Early dual #biologic therapy may overcome limits in severe #IBD. #GITwitter #MedTwitter https://t.co/RqnadklkZq
-
-
Mashup Score: 0Risankizumab improves symptoms, is well tolerated in psoriatic arthritis through 52 weeks - 1 year(s) ago
Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.“Although there are several therapeutic options available to treat PsA, there is a need for
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
ICYMI: #Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to #biologic therapies or conventional synthetic disease-modifying antirheumatic drugs https://t.co/BXbHUD9GBr
-
-
Mashup Score: 0Risankizumab improves symptoms, is well tolerated in psoriatic arthritis through 52 weeks - 1 year(s) ago
Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.“Although there are several therapeutic options available to treat PsA, there is a need for
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
#Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to #biologic therapies or conventional synthetic disease-modifying antirheumatic drugs https://t.co/BXbHUD9GBr
-
-
Mashup Score: 0
Approximately 14,280 more US patients with psoriasis were estimated to initiate a biologic in Spring than in other seasons, and over 840 more biologic users switched in Spring than in Winter.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Approximately 14,280 more US patients with #psoriasis were estimated to initiate a #biologic in Spring than in other seasons, and over 840 more biologic users switched in Spring than in Winter. Keep reading here: https://t.co/KIDLaHrt5E https://t.co/uEi1XWvNtX
-
-
Mashup Score: 0Racial and ethnic disparities in biologic prescriptions for asthma in the United States - 1 year(s) ago
In the United States, morbidity and mortality from asthma are declining, but racial and ethnic differences in asthma burden remain unresolved.1 Compared with White patients, individuals of underrepresented backgrounds have a higher prevalence of moderate-to-severe persistent asthma, difficult-to-treat asthma, and emergency room utilization for asthma care.2,3 Asthma biologics that target type 2…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Racial and #ethnic #disparities in #biologic #prescriptions for #asthma in the United States https://t.co/NDZCuKzO3X https://t.co/AUwVQexgS3
-
-
Mashup Score: 0Adding a Biologic to Asthma Therapy: The Role of Adherence in Selecting the Right Patient - 1 year(s) ago
The addition of biologics to the treatment of severe asthma has been a notable advance for patients previously unable to gain control of their asthma despite an optimized treatment plan. In this month’s issue, Bender et al1 describe the suboptimal levels of adherence for many patients escalated to biologics and provide evidence that a third of these patients do not meet the criteria for having…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Adding a #Biologic to #Asthma #Therapy: The Role of #Adherence in Selecting the Right Patient https://t.co/o60s7m6AxO
-
-
Mashup Score: 0Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients - 2 year(s) ago
Adherence barriers to asthma biologics may not be uniform across administration settings for patients with moderate-to-severe asthma.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! Factors Related to #Biologic #Adherence and #Outcomes #Among #Moderate-to- #Severe #Asthma #Patients https://t.co/umWhOqsuyi https://t.co/zYuVDCHyOg
-
Factors Associated with #Asthma #Biologic #Prescribing and #Primary #Adherence Among Adults in a Large #Health #System https://t.co/Jesnr5i5Ia https://t.co/8utR5iQqgs